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Eukaryotic cells are continuously threatened by unavoidable errors during normal DNA
replication or various sources of genotoxic stresses that cause DNA damage or stalled
replication. To maintain genomic integrity, cells have developed a coordinated signaling
network, known as the DNA damage response (DDR). Following DNA damage, sensor
molecules detect the presence of DNA damage and transmit signals to downstream
transducer molecules. This in turn conveys the signals to numerous effectors, which
initiate a large number of speciﬁc biological responses, including transient cell cycle
arrest mediated by checkpoints, DNA repair, and apoptosis. It is recently becoming
clear that dephosphorylation events are involved in keeping DDR factors inactive during
normal cell growth. Moreover, dephosphorylation is required to shut off checkpoint arrest
following DNA damage and has been implicated in the activation of the DDR. Spatial and
temporal regulation of phosphorylation events is essential for the DDR, and ﬁne-tuning
of phosphorylation is partly mediated by protein phosphatases. While the role of kinases
in the DDR has been well documented, the complex roles of protein dephosphorylation
have only recently begun to be investigated. Therefore, it is important to focus on the
role of phosphatases and to determine how their activity is regulated upon DNA damage.
In this work, we summarize current knowledge on the involvement of serine/threonine
phosphatases, especially the protein phosphatase 1, protein phosphatase 2A, and protein
phosphatase Mg2+/Mn2+-dependent families, in the DDR.
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INTRODUCTION
The DNA damage response (DDR) signaling network medi-
ates a wide variety of cellular events, including DNA repair,
cell cycle arrest, apoptosis, and premature senescence, to main-
tain genomic integrity. Loss of checkpoint function results in
chromosomal instability and aneuploidy, which promote tumori-
genesis, suggesting that proper checkpoint signaling is essential
for preventing cancer. From recent studies, it has become clear
that protein phosphorylation plays a major role in the regu-
lation of diverse DDR pathways. The initiation of some DDR
processes is mainly mediated by protein kinases in the phos-
phoinositide 3-kinase (PI3-K)-related kinase family, as well as
ataxia-telangiectasia mutated (ATM), ATM and Rad3-related
(ATR), and DNA-dependent protein kinase (DNA-PK). These
kinases orchestrate the cellular responses to DNA damage and
activate the multiple cascades involved in the DDR through phos-
phorylation of a variety of substrates (Shiloh, 2003). Effector
kinases, Chk1 and Chk2, are activated mainly by ATR and ATM,
respectively, and transmit signals to a variety of downstream
factors, such as p53, pRB, and Cdc25, ultimately leading to
inactivation of cyclin-dependent kinases (Cdks) and inhibiting
cell-cycle progression. Thus, studies have demonstrated that pro-
tein phosphorylation, mainly at serine (S)/threonine (T) residues,
is essential for the DDR and regulates enzymatic activity, local-
ization, protein–protein interactions, and stabilization. Given the
fact that ATM and ATR are known to have hundreds of substrates,
a large number of phosphorylation events are regulated and have
roles in the DDR, although the biological signiﬁcance of many
of these phosphorylation events is largely unknown. Indeed, the
catalytic subunits of protein phosphatases and their regulators
are also targets of ATM and ATR, suggesting that the activity
of protein phosphatases is regulated by phosphorylation during
the DDR.
Recent large proteomic analyses have revealed that most
phosphorylation events are tightly regulated both spatially and
temporally, suggesting that a comprehensive analysis of the tim-
ing and location of phosphorylation events, rather than analysis
of phosphorylation levels in whole cells, is essential to under-
stand the DDR. In recent years, it has become increasingly
clear that phosphatases, particularly S/T phosphatases, regulate
the DDR not only by counteracting the function of kinases,
but also by initiation of speciﬁc steps during the DDR. Given
that ﬁne-tuning of phosphorylation events is partly mediated
by phosphatases, studies should focus on the involvement of
protein phosphatases in the DDR and how their activity is reg-
ulated in vivo. In addition to phosphorylation, different types
of post-translational modiﬁcations also have important roles in
the DDR. Thus, it will be important to investigate the cor-
relation between phosphorylation/dephosphorylation and other
types of modiﬁcations. In this study, we summarize recent
reports that have revealed new functions of S/T phosphatases in
the DDR.
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INTRODUCTION TO THE DDR
Upon formation of DNA double-strand breaks (DSBs), ATM is
autophosphorylated at S1981 and then dissociates from an inac-
tive homodimer into active monomers (Bakkenist and Kastan,
2003). It has been reported that phosphorylation of ATM on
S367, S1893, and S1981 is required for ATM activation in human
cells (Bakkenist and Kastan, 2003; Kozlov et al., 2006). Contrary
to these ﬁndings, corresponding phosphorylation of these sites
are dispensable for murine ATM activation (Pellegrini et al., 2006;
Daniel et al., 2008). Instead of ATM activation, S1981 phospho-
rylation is required for ATM retention at sites of DSBs through
interaction with mediator of DNA damage checkpoint 1 (MDC1;
So et al., 2009). ATM is recruited to DSBs and activated by the
MRN complex (Mre11, Rad50, and NBS1) through the associa-
tion with NBS1 (Uziel et al., 2003; Falck et al., 2005; Lee and Paull,
2005). In response to DSBs, ATM phosphorylates histone H2AX
at S139 (termed γ-H2AX), which extends up to megabases away
from break sites that are readily visible as foci by immunoﬂuo-
rescence microscopy (Burma et al., 2001; Ward and Chen, 2001;
Shroff et al., 2004; Stiff et al., 2004). These γ-H2AX foci are colo-
calized with many proteins involved in the DDR, such as MDC1,
53BP1, BRCA1, and theMRN complex (Paull et al., 2000). Indeed,
γ-H2AX is required for the recruitment and maintenance of these
factors at damaged sites in order to transmit signals to downstream
factors.
Following single-stranded DNA (ssDNA) damage, replication
defects, or during the process of DSBs, ATR, which forms a com-
plex with ATRIP, is recruited to the region of replication protein A
(RPA)-coated ssDNA (Zou and Elledge, 2003). Rad17, associated
with small subunits of replication factor C (RFC), recognizes the
junctions between ssDNA and dsDNA and facilitates the loading
of the Rad9-Rad1-Hus1 (9-1-1 complex) sliding clamp onto the
DNA (Kondo et al., 2001;Melo et al., 2001; Zou and Elledge, 2003).
In concert with ATR/ATRIP and RPA, the 9-1-1 complex appears
to act as a sensor of DNA damage and interacts with TopBP1,
thereby loading it onto sites of DNA damage. Rad17 interacts
with Claspin to promote the phosphorylation of Chk1 (Roos-
Mattjus et al., 2002; Bermudez et al., 2003; Wang et al., 2006). All
of these proteins, i.e., ATRIP, RPA,RAD17, the 9-1-1 complex, and
TopBP1, are phosphorylated byATRduring checkpoint activation.
Through an interaction with TopBP1, ATR becomes fully active,
thereby inducing subsequent responses (Delacroix et al., 2007;
Lee et al., 2007a).
ATR and ATM phosphorylate and activate the effector kinases
Chk1 and Chk2, respectively. Chk1 is composed of N-terminal
catalytic domain and a regulatory C-terminus, which nega-
tively regulates Chk1 kinase activity. Several reports have iden-
tiﬁed the functional roles of Chk1 phosphorylation in vivo. In
response to cellular stresses, Chk1 phosphorylation occurs pri-
marily on 2 residues, S317 and S345 (Liu et al., 2000; Zhao and
Piwnica-Worms, 2001). Phosphorylated Chk1 is released from
chromatin and accumulates in the cytoplasm to prevent acti-
vation of Cdk1 and entry into mitosis (Kramer et al., 2004).
Phosphorylation of the C-terminal residues (mainly S317 and
S345) block intramolecular interactions, reversing this auto-
inhibition mechanism (Katsuragi and Sagata, 2004). Regardless
of this negative regulatory mechanism, Chk1 has basal activity
in its unmodiﬁed form, and this activity is sufﬁcient to phos-
phorylate several substrates, including histone H3 at T11 and
Aurora B (Falck et al., 2005; Shimada et al., 2008). Thus, phos-
phorylation of S317 and S345 induces conformational changes
that permit full activation and spatiotemporal regulation of Chk1
(Katsuragi and Sagata, 2004; Ng et al., 2004; Clarke and Clarke,
2005; Smits et al., 2006; Lofﬂer et al., 2007; Niida et al., 2007).
Upon DSBs, Chk2 is phosphorylated at T68 by ATM, which
triggers Chk2 dimerization and activation by autophosphoryla-
tion of residues T383 and T387 in the T-loop (Ahn et al., 2000;
Melchionna et al., 2000; Xu et al., 2002). Given that chromatin-
bound Chk2 is dissociated from chromatin in response to ionizing
radiation (IR), this notion also suggests that Chk2, when local-
ized other than undamaged sites, may allow further activation
of downstream effectors (Li and Stern, 2005). Although bio-
chemical analyses revealed that Chk2 can phosphorylate Cdc25A,
Cdc25C, BRCA1, and p53, examination of Chk2-deﬁcient mice
and cells showed that Chk2 functions mainly in p53-dependent
apoptosis (Jack et al., 2002). It is noteworthy that Chk2 and
Chk1 have partially redundant roles and share multiple sub-
strates (Bartek and Lukas, 2003; Uziel et al., 2003; Lee and
Paull, 2005). However, despite their overlapping roles in check-
point signaling, the biological requirements for Chk1 and Chk2
function are strikingly different (Bartek and Lukas, 2003). In
any case, these checkpoint kinases phosphorylate effector mole-
cules, such as p53 and Cdc25 proteins, to induce cell cycle arrest
(Sanchez et al., 1997; Hirao et al., 2000; Shieh et al., 2000; Falck
et al., 2001).
DNA-dependent protein kinase plays a critical role in DNA
damage repair, especially in non-homologous end-joining (NHEJ)
repair of DSBs. DNA-PK is composed of three factors, a cat-
alytic subunit (DNA-PKcs), Ku70, and Ku80, the latter two of
which form a Ku heterodimer, and is essential for NHEJ to
repair DNA DSBs. The Ku70/Ku80 heterodimer ﬁrst binds to
each broken DNA strand, after which DNA-PKcs is recruited
to the DNA ends through interaction with the Ku heterodimer
(Gottlieb and Jackson, 1993), promoting DNA repair. Impor-
tantly, DNA-PKcs is autophosphorylated at multiple sites and
the regions of 2023–2056 and 2609–2647 are identiﬁed as major
autophosphorylation clusters (Ding et al., 2003; Block et al., 2004;
Chen et al., 2005; Cui et al., 2005). Among them, S2056 and
T2609 are phosphorylated following IR and extensively stud-
ied. Such autophosphorylation of DNA-PKcs is important for
end processing, disassembly, and inactivation (Merkle et al.,
2002). Functional analysis using hypo- or hyperphosphory-
lated mutations of DNA-PKcs suggest that timely phosphoryla-
tion and dephosphorylation are essential for its function (Chan
et al., 2002).
DYNAMIC CHANGES IN PROTEIN PHOSPHORYLATION
FOLLOWING DNA DAMAGE
Protein phosphorylation is one of the most common post-
translational modiﬁcations and is known to control many cellular
processes. The phosphorylation state of a protein represents a
balance between the activity of protein kinases and protein phos-
phatases. It has been reported that one-thirdof cellular proteins are
phosphorylated, and more than 98% of protein phosphorylation
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occurs on S and T residues (Olsen et al., 2006). Recently, sev-
eral large-scale proteomic studies have revealed that ATM and
ATR phosphorylate hundreds of proteins, which are involved
in proliferation, cell structure, transcription, metabolic signal-
ing, and RNA splicing (Matsuoka et al., 2007; Smolka et al.,
2007; Stokes et al., 2007; Virshup and Shenolikar, 2009). Thus,
ATM and ATR coordinate a much wider variety of cellular
activities than initially expected. Protein phosphatase catalytic
subunits and a number of their regulators were identiﬁed by
these screens, suggesting that they play a role in the DDR down-
stream of ATM/ATR, although the functional meaning of these
phosphorylation events has not been investigated. Large phospho-
proteomic analyses performed in later studies reported dynamic
and temporal aspects of phosphorylation and dephosphoryla-
tion following DSBs (Bennetzen et al., 2010; Bensimon et al.,
2010). Bennetzen et al. (2010) classiﬁed the temporal proﬁles
of nearly 600 regulated phosphorylation sites on 209 proteins
and revealed that sites phosphorylated shortly after DSBs are
enriched in SQ motifs, which are targets of ATM/ATR/DNA-
PK, and in novel SXXQ motifs. Importantly, they identiﬁed a
considerable number of sites that are dephosphorylated imme-
diately after DNA damage. Bensimon et al. (2010) also per-
formed quantitative phosphoproteomics and showed that 40%
of DSB-induced phosphorylation events are ATM-independent.
In addition, among ATM-dependent phosphorylation events,
75% are not located in SQ/TQ motifs, indicating the involve-
ment of additional kinases activated by ATM. Similar to the
results described by Bennetzen et al. (2010), Bensimon et al.
(2010) found that more than 300 sites are dephosphorylated
following DSBs among approximately 750 regulated phospho-
rylation sites on nearly 400 proteins; however, the functions
of most of these dephosphorylation events have not yet been
identiﬁed. Protein phosphatases contribute to shutting off DSB-
induced phosphorylation during the late DDR; thus, these
proteomic analyses suggested an additional function of phos-
phatases, which play a primary role in initiating some DDR
processes.
PROTEIN PHOSPHATASES
The mammalian genome encodes nearly 500 protein kinases, 400
of which are S/T kinases. In contrast, the number of protein
phosphatase catalytic subunits (e.g., catalytic subunit of PP1 is
referred as PP1C) has been estimated to be 147, of which only
about 40 are S/T phosphatases (Moorhead et al., 2007). The fact
that so few S/T phosphatases counteract hundreds of distinct
S/T kinases can be explained by the ability of phosphatases to
form distinct components in vivo. Based on sequence, struc-
ture, and biological properties, S/T phosphatases can be classiﬁed
into Mg2+/Mn2+-dependent phosphatases (PPMs) and the more
diverse phosphoprotein phosphatases (PPPs). Among the PPP
family, PP1 and PP2A are the most abundant isoforms, and their
substrates have been relatively well characterized. PP1 and PP2A
catalytic subunits interact with a vast number of regulators that
target them to speciﬁc locations, mediate substrate speciﬁcity, and
ﬁne-tune phosphatase activity. In fact, mammalian cells contain
more than 600 distinct PP1 complexes and approximately 70 PP2A
holoenzymes (Ding et al., 2003).
PP1
PP1 catalyzes the majority of protein dephosphorylation events
that regulate diverse cellular processes, such as neuronal signaling,
muscle contraction, glycogen synthesis, and cell proliferation.
Mammals have three PP1 catalytic genes, PP1α, -γ, and -δ, which
encode very closely related proteins showing more than 85% sim-
ilarity, with minor differences primarily at their NH2 and COOH
termini (Cohen, 2002). PP1γ has 2 isoforms, γ1 and γ2, generated
by differential splicing of PP1γ. PP1 isoforms are expressed in
all tissues and are widely distributed, except for PP1γ2, which
is found only in the testes (Shima et al., 1993). PP1 isoforms
show distinct subcellular localization, suggesting distinct roles and
substrates for these enzymes (Andreassen et al., 1998). However,
only a few reports have demonstrated speciﬁc differences for PP1
isoforms, since they do not show strict substrate speciﬁcities in
vitro and have overlapping functions in most cases. Speciﬁcity
is provided to PP1C through association with a large number
of regulatory subunits that target catalytic subunits to speciﬁc
subcellular localization, modulate their activity, and determine
substrate speciﬁcity. Importantly many proteins involved in the
DDR, including BRCA1, pRB, 53BP1, and Cdc25, harbor a PP1c-
bindingmotif, RVxF (Ding et al., 2003; Kuntziger et al., 2011), and
are targets of PP1.
The activity of PP1 is regulated by regulatory subunits such
as protein phosphatase 1 nuclear targeting subunit (PNUTS),
nuclear inhibitor of protein phosphatase 1 (NIPP1), inhibitor 2
(I2), and recruits PP1 onto mitotic chromatin at anaphase (Repo-
Man). Most forms of regulation are also achieved through the
regulatory subunits; however, phosphorylation of PP1 by Cdk is
also important for its activity. Nuclear PP1 shows higher activ-
ity in G0/G1 and G2/M, and this change can be explained by
Cdk-dependent phosphorylation of PP1 in its C-terminus. Cdk
phosphorylates PP1α on T320, reducing its activity (Dohadwala
et al., 1994; Berndt et al., 1997; Kwon et al., 1997). The equivalent
T residue is conserved in all three PP1 isoforms (T316 in PP1β
and T311 in PP1γ), and indeed, PP1γ is also inactivated by Cdk-
dependent T311 phosphorylation (Shimada et al., 2010). Mice
with depleted PP1γ are viable, but males show defective spermio-
genesis and are infertile (Varmuza et al., 1999). These ﬁndings
suggest that PP1α and/or -β could compensate for the depletion of
PP1γ in development, but not in the speciﬁc function of spermio-
genesis.
THE PP2A FAMILY
PP2 is further divided into three groups on the basis of metal-
dependence: metal-independent PP2A, PP4, PP5, and PP6;
Ca2+-dependent PP2B and PP7; and Mg2+/Mn2+-dependent
PP2C. Among the metal-independent group members, PP4
and PP6 share high homology with PP2A and are referred as
PP2A-like phosphatases. Recent reports revealed that PP2A-like
phosphatases have overlapping substrates and roles in the DDR.
PP2A
PP2A often functions as a heterotrimer, comprising three subunits
designated A, B, and C. The core enzyme consists of the catalytic
C subunit, scaffold A subunit, and variable regulatory B subunit.
The regulatory B subunit deﬁnes the substrate speciﬁcity of the
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PP2A holoenzyme and comprises four families: PR55/B (B55),
PR61/ B′ (B56), PR72/B′′, and striatins/SG2NA/B′′′. Each one
of these families contains various isoforms, which, when com-
bined with the isoforms of both A and C subunits, produce a
variety of PP2A holoenzymes that perform distinct functions.
Depletion or inhibition of PP2A activity in Xenopus egg extracts
inhibits the initiation of DNA replication by preventing binding
of the initiation factor Cdc45 onto prereplication complexes (Lin
et al., 1998; Chou et al., 2002). Additionally, recent studies have
uncovered important roles for PP2A in the DDR. For example,
PP2A is essential for the activation of ATM, ATR, Chk1, Chk2,
and p53 and mediates G2/M checkpoint control through regu-
lation of the phosphorylation states of these proteins, although
phosphorylation of Chk2 at T68, ATR at S428, and Chk1 at
S317 is observed even in irradiated cells lacking PP2A activity
(Yan et al., 2010).
PP4
PP4 is structurally and functionally related to PP2A and shares
65% amino acid identity with PP2A. PP4c associates with the reg-
ulatory subunits PP4R1, PP4R2, PP4R3α, PP4R3β, and PP4R4
(Cohen et al., 2005; Chen et al., 2008). Recent reports have demon-
strated that PP4 possesses various cellular functions, including
roles in nucleation, growth, and stabilization of microtubules
at centrosomes/spindle bodies during cell division (Brewis et al.,
1993; Helps et al., 1998; Hastie et al., 2000; Sumiyoshi et al., 2002).
PP4 is localized predominantly to the nucleus, but some PP4 is
present in cytoplasm and in mitotic centrosomes. Importantly,
depletion of PP4 leads to embryonic lethality in mice, and PP4
deﬁciency in thymocytes results in decreased proliferation, indi-
cating the essential role of PP4 in development and cell growth
(Shui et al., 2007). Thanks to the functional analysis of newly iden-
tiﬁed PP4 substrates, our understanding of the role of PP4 in the
DDR has also grown. Indeed, PP4 is involved in recovery from
the G2/M checkpoint arrest after IR and required for cell survival
in the presence of DNA replication inhibitors (Chowdhury et al.,
2008; Nakada et al., 2008).
PP5
Unlike other related phosphatases, PP5 contains tetratricopep-
tide repeat (TPR) domains at the N-terminus. A catalytic domain
and an auto-inhibitory domain are located at the C-terminus
(Chinkers, 2001). Moreover, unlike other related phosphatases,
whose substrate speciﬁcity is mediated by regulatory subunits,
PP5 is regulated by protein–protein interactions through the TPR
motif. Thus far, PP5 has been reported to interact with several
proteins involved in the regulation of steroid signaling (Chen et al.,
1996; Silverstein et al., 1997), cell cycle progression (Ollendorff and
Donoghue, 1997; Zuo et al., 1998), and apoptosis (Morita et al.,
2001) via the TPR domain. In addition, PP5 has been reported to
be less abundant than other phosphatases, and has been shown to
have low basal activity (Chinkers, 2001). PP5 knockout mice are
viable, and the replication checkpoint is intact; however, the G2/M
checkpoint is impaired inPP5-knockoutmouse embryonic ﬁbrob-
lasts (MEFs), indicating the essential function of PP5 in the DDR
as general regulator of ATM,ATR, DNA-PK, or their substrates, as
discussed below (Yong et al., 2007).
PP6
PP6 forms stable heterotrimers, comprising the PP6 catalytic
subunit (PP6c), one of the three regulatory subunits (PP6R1,
PP6R2, or PP6R3), and one of the three ankyrin repeat-containing
subunits (ARS-A, ARS-B, or ARS-C; Stefansson and Brauti-
gan, 2006; Stefansson et al., 2008). Functional analysis of PP6
showed that PP6 regulates G1 to S progression through con-
trolling cyclin D1 protein expression (Stefansson and Brautigan,
2007) and mitotic spindle formation through inhibition of an
essential mitotic kinase, Aurora A (Zeng et al., 2010). Knock-
down of either PP6R1 or PP6c impairs DNA-PK activation,
DSB repair, and IR sensitivity, indicating that PP6 has critical
roles in the DDR (Mi et al., 2009b; Douglas et al., 2010; Zhong
et al., 2011).
PP2C
Wip1/PPM1D
PP2C belongs to the Mn2+/Mg2+-dependent PPM family. Unlike
the PPP family, PP2C phosphatases are insensitive to inhibition
by okadaic acid (OA) or microcystin and do not have regula-
tory subunits, but instead contain speciﬁc regulatory and targeting
domains. Among thePP2Cphosphatases,wild-typep53-inducible
phosphatase 1 (Wip1), also termed PPM1D, which was originally
identiﬁed in a screen for p53 target genes (Fiscella et al., 1997), has
been extensively analyzed in cell cycle checkpoint contexts. Wip1
preferentially targets multiple proteins at their pSQ/pTQ motifs,
which are phosphorylated by ATM, ATR, or DNA-PK. In addi-
tion, Wip1 also targets pTXpY motifs in p38 mitogen-activated
protein kinase (MAPK), which activates p53 upon DNA dam-
age, and in the uracil DNA glycosylase UNG2, which regulates
base excision repair (BER; Lu et al., 2004; Takekawa et al., 2000).
Wip1 has also been reported to facilitate the reversal of cell cycle
checkpoint responses, returning cells to the homeostatic state after
completion of DNA repair. Wip1 likely plays a role in the p53
negative feedback loop through two pathways, i.e., dephosphory-
lation of p38 or p53. Following DNA damage, p53 up-regulates
Wip1, which then inhibits p38 via dephosphorylation at T180;
inactivated p38 results in inhibition of p53 (Bulavin et al., 1999;
Appella and Anderson, 2001). On the other hand, up-regulation
of Wip1 reverses p53 activation by dephosphorylating p53 at S15
(Lu et al., 2005). UNG2, another target of Wip1, is phospho-
rylated and activated in response to UV, inducing BER activity.
Wip1 also inhibits BER activity through dephosphorylation of
UNG2 at T6 after completion of DNA repair (Lu et al., 2004).
Importantly, mice lacking Wip1 are viable but exhibit defects in
reproductive organs, immune functions, and cell cycle control
(Choi et al., 2002). Knockout of Wip1 triggers p38-mediated acti-
vation of the p53, p16, and p19 pathways, leading to enhanced
DDRs, promoting genomic stability, and providing resistance to
transformation by oncogenes (Bulavin et al., 2004). Consistent
withWip1’s function as anoncogene, ampliﬁcationof this genehas
been reported in several human tumors, including breast cancer,
neuroblastoma, and ovarian clear cell adenocarcinoma (Bulavin
et al., 2002; Li et al., 2002; Hirasawa et al., 2003; Saito-Ohara
et al., 2003). In fact, an associated checkpoint phenotype was
reported; overexpressed Wip1 cells abrogated S phase and G2/M
DNA damage checkpoints, whereas reduction of Wip1 expression
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enhanced the enforcement of intra-S and G2/M checkpoints (Lu
et al., 2005).
PPM1G
PPM1G (also denoted PP2Cγ), a PP2C phosphatase what was
originally identiﬁed as a splicing factor, has a role in the DDR.
PPM1G mediates the exchange of H2A-H2B, which is impli-
cated in the recovery from DNA damage (Kimura et al., 2006).
PPM1G-knockdown cells show defects in normal cell prolifer-
ation (Allemand et al., 2007), and PPM1G-deﬁcient DT40 cells
are sensitive to DNA damage (Kimura et al., 2006), indicating the
important role of PPM1G in cell growth and the DDR. Recently,
another report demonstrated that PPM1G has a new function in
p53 activation through the deubiquitinating enzyme USP7 (also
known as HAUSP), which stabilizes the E3 ligase Mdm2 (Khoro-
nenkova et al., 2012). In fact, following IR, ATM phosphorylates
and activates PPM1G, which then dephosphorylates and inac-
tivates USP7, leading to Mdm2 degradation and accumulation
of p53.
DDR PLAYERS ARE DEPHOSPHORYLATED BY PROTEIN
PHOSPHATASES
SENSOR KINASES, ATM, ATR, AND DNA-PK
PP2A
PP2A has been reported to operate as a regulator of ATM
(Goodarzi et al., 2004). In the absence of DNA damage, PP2A
associates with and dephosphorylates ATM at S1981 (Figure 1A).
Following DNA damage, rapid dissociation of PP2A from ATM
leads to activation of ATM. Inhibition of PP2A by OA or
by expressing a dominant-negative mutant of PP2Ac induces
autophosphorylation of ATM at S1981 in undamaged cells with-
out activation of ATM activity (Yan et al., 2010). Other reports
demonstrated that IR induces dissociation of the B55 subunit from
PP2A in an ATM-dependent manner, inﬂuencing the disruption
of ATM-PP2A (Guo et al., 2002). Despite these studies, the molec-
ularmechanism regulating the dissociation of ATM-PP2A remains
to be determined.
Little is known about the role of PP2A in mediating DNA-
PK. Studies have shown that the interaction of PP2A with the
DNA-PK subunits Ku70 and Ku80 is induced by DSBs. Moreover,
PP2A has been shown to dephosphorylate each of these proteins
both in vitro and in vivo (Figure 1C). Further functional analy-
ses showed that PP2A-dependent dephosphorylation of DNA-PK
subunits enhances the formation of a functional DNA-PK, leading
to promotion of NHEJ andDSB repair (Douglas et al., 2001;Wang
et al., 2009).
PP1
PP1-dependent DDR regulation is partly mediated by its chro-
matin targeting subunit, Repo-Man, which was isolated as a
PP1γ-speciﬁc interacting protein (Trinkle-Mulcahy et al., 2006;
Vagnarelli et al., 2006). Studies in Xenopus egg extracts demon-
strated that Repo-Man interacts with ATM and PP1 through
distinct domains, leading to PP1-dependent regulation of ATM
phosphorylation and activation (Peng et al., 2010; Figure 1A).
Following DNA damage, the Repo-Man-PP1γ complex is released
from chromatin, leading to activation of ATM at DNA damage
sites.
Wip1
Wip1 suppresses ATM activity through dephosphorylation of
ATM, resulting in restoration of ATM to its dephosphorylated state
after completion of DNA repair (Shreeram et al., 2006; Figure 1A).
Given the fact thatWip1 is constitutively associatedwithATM,how
Wip1 activity is regulated remains to be determined.
PP5
Unlike the phosphatases described above, PP5 has a role in the
activation of ATM and the association between ATM and PP5 is
induced by DNA damage (Ali et al., 2004). Following DSBs, ATM-
mediated phosphorylation of Rad17 at pS635 and p53 at S15 is
not induced in PP5-knockdown cells, which exhibit an impaired
S-phase checkpoint (Ali et al., 2004). In fact, expression of a cat-
alytically inactive PP5 mutant inhibits ATM activation, whereas
wild-type PP5 does not affect the phosphorylation status of ATM
at S1981 after IR exposure (Ali et al., 2004; Wechsler et al., 2004).
These results suggest that PP5 is likely not involved in dephospho-
rylation of this site, but instead may be involved in the activation
of ATM (Figure 1A).
Regulatory links between PP5 andATR as well as PP5 andATM
have been demonstrated (Zhang et al., 2005). PP5 interacts with
ATR in a DNA damage-dependent manner, and down-regulation
of PP5 leads to defects in the phosphorylation of ATR targets,
including Rad17 and Chk1, following UV or HU and an aber-
rant S-phase checkpoint, indicating the involvement of PP5 in
ATR activation (Figure 1B). Whether ATR is a substrate of PP5
currently remains unknown.
PP5 interacts with and dephosphorylates DNA-PKcs (Wechsler
et al., 2004; Figure 1C). Phosphorylation of DNA-PKcs at T2609
and S2056 is reduced in cells overexpressing PP5, suggesting that
PP5 mediates dephosphorylation of DNA-PKcs.
PP6
DNA-PKcs associate with PP6 and all regulatory subunits, includ-
ing PP6R1, PP6R2, and PP6R3, and PP6 is involved in dephos-
phorylation of DNA-PKcs (Mi et al., 2009b; Douglas et al., 2010;
Figure 1C). IR enhances this interaction and promotes the import
of this complex into the nucleus (Mi et al., 2009b). In contrast,
other ﬁndings have indicated that the interaction between DNA-
PKcs and the PP6 complex is constitutive (Douglas et al., 2010).
Although it is not clear whether the interaction between DNA-
PKcs and PP6 is indeed induced by DNA damage, Douglas et al.
(2010) produced an attractive model in which DNA-PKcs recruit
PP6 complexes to damaged sites, permitting PP6 to contribute to
the dephosphorylation of H2AX, dissolution of foci, and release
from the G2/M checkpoint.
BAAT1
BRCA1-associated protein required for ATM activation 1
(BAAT1), which was isolated as a BRCA1-interaction partner, is
important for activation of ATM (Aglipay et al., 2006; Figure 1A).
Expression of BAAT1 and association of BAAT1 with ATM are
increased after IR. Importantly, phosphorylation of several ATM
targets, including H2AX, NBS1 at S343, Chk2 at T68, and ATM
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FIGURE 1 | Protein phosphatases regulate multiple phosphorylation
events in the DNA damage response. (A) PP1, PP2A, andWip1
dephosphorylate ATM at S1981, which is required for the recruitment ATM to
damage sites. BAAT1 protects ATM from dephosphorylation by
phosphatases. PP5 is likely involved in ATM activation through
dephosphorylation of ATM, which may induce ATM phosphorylation at S1981.
(B) PP5 is required for ATR- targeted phosphorylation of Rad17 and Chk1.
Although PP5 associates with ATR in a DNA damage-dependent manner, the
precise mechanism remains to be determined. (C) PP2A, PP5, and possibly
PP6 dephosphorylate multiple sites on DNA-PK, including S2056 and S2609.
These sites are autophosphorylated by DNA-PK and are involved in the
activation/inactivation of DNA-PK. (D) PP1 (S. pombe), PP2A, andWip1
dephosphorylate Chk1 at S317 and/or S345, which promotes its release from
chromatin and increases Chk1 kinase activity. (E) PP2A andWip1 mediate the
dephosphorylation of Chk2 at T68, which facilitates Chk2 dimerization and
(Continued)
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FIGURE 1 | autophosphorylation at T383 andT387. (F) γ-H2AX (the
phosphorylated form of H2AX at S139) is required for recruitment of
various DDR proteins to damaged sites and is dephosphorylated by PP2A,
PP4, PP6, andWip1. Rvb1/Tip60 is implicated in the removal of γ-H2AX.
(G) PP1 dephosphorylates H3 at T11 following DNA damage, leading to
transcriptional repression of cell cycle-regulated genes. (H) PP2A and
PP1-PNUTS dephosphorylate pRb at multiple sites, leading to inhibition of
E2F1 activity and cell cycle arrest. (I) p53 is dephosphorylated at S15 by
PP1-GADD34, PP1-PNUTS, andWip1, resulting in p53 inactivation. S37
dephosphorylation is also mediated by PP1 and PP2A. PP2A also
dephosphorylates p53 at S46 andT55. (J)Wip1 and PP1 dephosphorylate
Mdm2 at S395, which facilitates p53 degradation. (K) PP1 interacts with
BRCA1 and dephosphorylates multiple sites of BRCA1. In addition to
acting as a PP1 substrate, BRCA1 also plays a role in PP1 inhibition.
(L) KAP-1 is dephosphorylated at S473 by PP1 and PP4, whereas S824 is
dephosphorylated by PP4. (M) PP2A and PP4 are required for RPA2
dephosphorylation. (N) Phosphorylated 53BP1 is recruited to DNA
damage sites to coordinate the localization of DDR factors and promote
their activation. PP5 dephosphorylates 53BP1 at S1778, leading to 53BP1
release from DNA damage sites.
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at S1981, is not induced in BAAT1-knockdown cells. Defects in
ATM phosphorylation at S1981 observed in BAAT1-knockdown
cells could be restored by OA treatment.
TRANSDUCER KINASES, Chk1/Chk2
PP2A
During the normal unperturbed cell cycle, Chk1 is phosphory-
lated on S317 and S345 by ATR, and in turn, phosphorylated
Chk1 is antagonized by Chk1-regulated PP2A to maintain the sta-
tus of Chk1 activity (Figure 1D). Thus, the activity of Chk1 is
ﬁnely tuned in an ATR-Chk1-PP2A regulatory loop (Leung-
Pineda et al., 2006).
PP2A was also reported to interact with Chk2 and regulates
phosphorylation at T68 of Chk2 after DNA damage (Dozier et al.,
2004; Liang et al., 2006; Freeman et al., 2010; Figure 1E). Stud-
ies have suggested that PP2A maintains Chk2 in an inactive state
under normal conditions, while PP2A dissociates from Chk2 and
permits the phosphorylation of Chk2 byATMunderDNAdamage
conditions. After completion of DNA repair, PP2A has a role in
attenuating the DDR partly through dephosphorylation of Chk2.
Wip1
Wip1 binds Chk1 and dephosphorylates S345 and, to a lesser
extent, S317, leading to inhibition of Chk1 activity (Lu et al.,
2005; Figure 1D). Thus, Wip1 has a role in abrogating cell cycle
checkpoints, in part through dephosphorylation of Chk1.
Wip1 also interacts with Chk2 and dephosphorylates Chk2 at
T68 (Fujimoto et al., 2006; Oliva-Trastoy et al., 2007; Figure 1E).
Knockdown of Wip1 leads to sustained phosphorylation of Chk2
at T68, promoting apoptosis in response to DNA damage. Con-
sistent with this observation, overexpression of Wip1 antagonizes
Chk2 activation. Thus, Wip1 is thought to play a negative role
in DNA damage-induced apoptosis by dephosphorylation and
inactivation of Chk2.
PP5
Upon UV irradiation, ATR-mediated phosphorylation of Chk1 at
S345 is increased andmaintained in PP5-depleted cells. After 24-h
exposure toUV irradiation, this site is dephosphorylated to control
levels, indicating that PP5 is not the only phosphatase mediating
Chk1 at S345 (Amable et al., 2011). Importantly, PP5-knockout
MEFs also exhibit prolonged and enhanced phosphorylation of
Rad17, H2AX, and Chk1 at S317. However, contrary to this obser-
vation, one study has shown that knockdown of PP5 by antisense
PP5 or ectopic expression of a catalytically inactive PP5 mutant
leads to impairment of the ATR-mediated phosphorylation of
Rad17 and Chk1 (Zhang et al., 2005). The precise functions of
PP5 in the DDR remain to be determined.
PP1
The involvement of PP1 in checkpoint recovery is less well stud-
ied. However, a study in Schizosaccharomyces pombe demonstrated
that dephosphorylation of Chk1 by the PP1 homolog Dis2 allows
mitotic entry upon completion of DNA repair in G2 phase (den
Elzen and O’Connell, 2004; Figure 1D). However, in human cells,
knockdown of PP1 does not change the phosphorylation status of
Chk1 on S317, and PP1 does not dephosphorylate Chk1 directly
(Leung-Pineda et al., 2006).
HISTONES AND HISTONE VARIANTS
H2AX-pS139 (γ-H2AX)
PP4 PP4 dephosphorylates γ-H2AX in vitro, and knockdown
of PP4 shows persistent γ-H2AX without apparent deﬁciencies
in DNA repair following IR, suggesting that PP4 has a direct
role in the dephosphorylation of γ-H2AX (Nakada et al., 2008;
Figure 1F). Indeed, PP4C knockdowned cells display a pro-
longed G2/M checkpoint arrest after IR. It is also reported that
PP4 is required to repair DNA replication-mediated DNA damage
and PP4 silenced cells are sensitive to DNA replication inhibitors
(Chowdhury et al., 2008).
PP2A In response to DNA damage, PP2A forms foci and colo-
calizes with γ-H2AX and dephosphorylates γ-H2AX (Chowdhury
et al., 2005; Figure 1F). However, since repair of damaged DNA
is delayed in PP2A-depleted cells, the PP2A-dependent increase in
γ-H2AX may be partly due to reduced repair (Chowdhury et al.,
2005; Nakada et al., 2008).
PP6 Down-regulation of either PP6C or PP6R1 causes extensive
γ-H2AX and persistent γ-H2AX foci formation following DNA
damage, suggesting that PP6 plays a role in the dephosphorylation
of γ-H2AX (Douglas et al., 2010; Figure 1F). It is important to
note that knockdown of PP6 did not affect the phosphorylation
of ATM at S1981, SMC1 at S957, or Chk2 at T68 (Douglas et al.,
2010). In the context of cisplatin-induced DSBs, PP6 is required
for homologous recombination; thus, persistent γ-H2AX in
PP6-depleted cells can be explained by delayed DSB repair (Zhong
et al., 2011).
Wip1 A recent study reported thatWip1 binds directly to H2AX
and dephosphorylates it in vitro and in vivo, leading to reverse
checkpoint signaling (Cha et al., 2010; Figure 1F). Moreover,
ectopic expression of Wip1 reduces IR-induced γ-H2AX and foci
formation for several DDR factors, leading to delayed DNA repair
after IR.However,whether knockdownofWip1 affectsDNArepair
efﬁciency remains unknown.
Histone H3
PP1 We have recently identiﬁed a novel function for Chk1 as
a transcriptional regulator through phosphorylation of H3 at
T11 (H3-pT11; Shimada and Nakanishi, 2008; Shimada et al.,
2008). This phosphorylation appears to activate the GCN5 his-
tone acetyltransferase complex, leading to H3K9 acetylation and
transcription of critical cell cycle regulatory genes, such as cdk1
and cyclin B1. Upon DNA damage, Chk1 rapidly dissociates from
chromatin, H3T11 phosphorylation and H3K9 acetylation lev-
els are reduced, and target genes are repressed. In addition to
release of Chk1 from chromatin, we recently reported that acti-
vation of protein phosphatase 1 is involved in the reduction of
H3-pT11 following DNA damage through suppression of T311
phosphorylation due to decreased Cdk1 activity (Shimada et al.,
2010; Figure 1G).
THE EFFECTOR MOLECULES pRb, p53, AND Mdm2
PP1
Retinoblastoma tumor suppressor protein (pRb), which is neg-
atively regulate cell cycle progression, can interact with all PP1
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isoforms (Durfee et al., 1993; Vietri et al., 2006), and PP1 dephos-
phorylates and activates pRb at the mitosis-to-interphase transi-
tion (Alberts et al., 1993; Durfee et al., 1993; Ludlow et al., 1993;
Nelson et al., 1997; Figure 1H). Importantly, recent data revealed
that PP1 competes with Cdks for binding to pRb (Hirschi et al.,
2010). PP1 regulatory factors have also been implicated in the
regulation of pRb. One of the regulatory subunits, PNUTS disso-
ciates from PP1 under hypoxia stress, leading to activation of PP1,
dephosphorylation of pRb at T821, and inhibition of cell growth
(Udho et al., 2002; Krucher et al., 2006). Importantly, depletion of
PNUTS in cancer cells, but not in normal cells, induces apoptosis
through the activation of PP1 and its subsequent regulation of
pRb (Krucher et al., 2006; De Leon et al., 2008).
p53 is phosphorylated on pS15 upon DNA damage by
ATM/ATR and contributes to stabilization and activation of p53
(Dumaz and Meek, 1999; Lu et al., 2005). Phosphorylation of p53
at S37, which is also transiently up-regulated upon DNA dam-
age, is required for p53 transcriptional activity (Dohoney et al.,
2004). PP1 dephosphorylates p53 at S15 and S37 in vitro and in
vivo, reducing transcriptional activity and attenuating apoptosis
(Li et al., 1998, 2006; Figure 1I). Growth arrest and DNA dam-
age 34 (GADD34) is known to inhibit the binding of PP1 to p53
and prevent dephosphorylation of p53 at S15 (Li et al., 1998).
In addition to GADD34, PNUTS also inhibits PP1-dependent
dephosphorylation of p53 at S15 and plays a role in apoptosis
via regulation of p53 (Lee et al., 2007b). Thus, the association
of regulators such as GADD34 and PNUTS with PP1 is required
PP1-mediated regulatory activity.
p53 is also regulated indirectly through Mdm2. DNA damage-
induced phosphorylation of Mdm2 at S395 byATM attenuates the
ability ofMdm2 topromotenuclear export anddegradep53 (Maya
et al., 2001). Once p53 is stabilized and activated, PP1 triggers
the inactivation of the signaling cascade (Figure 1J). Dephos-
phorylation of Mdm2 inhibits it autoubiquitination, resulting in
stabilization, which triggers degradation of p53 (Lu et al., 2007).
PP2A
PP2ACphysically associates with pRb, p107, and p130 in vivo (Cic-
chillitti et al., 2003; Garriga et al., 2004) and mediates oxidative
stress-induced dephosphorylation of these proteins (Cicchillitti
et al., 2003; Magenta et al., 2008). pRb can also be dephospho-
rylated by PP2A after IR, which may trigger the recruitment of
pRb to replication initiation sites, thereby suppressing abnormal
replication (Avni et al., 2003; Figure 1H).
PP2A binds to p53 following IR and dephosphorylatesmultiple
sites, S37, S46, and T55 to control p53 activity (Dohoney et al.,
2004; Li et al., 2004; Mi et al., 2009a; Figure 1I). Under normal
cell growth conditions, p53 is phosphorylated at T55 by TATA box
binding protein-associated factor 1 (TAF1), resulting in Mdm2-
mediated p53 degradation (Li et al., 2004). In response to DNA
damage, two reactions trigger dephosphorylation of p53 at T55
and stabilization of p53. One is mediated by the dissociation of
TAF1 fromp53,while the other occurs throughdephosphorylation
of B56γ-containing PP2A complexes (Li et al., 2007). B56γ and
PP2AC levels are increased upon DNA damage, contributing to
PP2A-mediated dephosphorylation of p53 at T55 (Dohoney et al.,
2004; Li et al., 2007).
Wip1
Wip1 can dephosphorylate p53 on S15 in vitro (Lu et al., 2005;
Figure 1I). In addition, ectopic expression of Wip1 decreases
p53 protein levels and S15 phosphorylation, whereas knockdown
of Wip1 results in increased p53 protein levels and S15 phos-
phorylation. Thus, Wip1 mediates dephosphorylation of p53
at S15.
Wip1 is also known to target Mdm2 at S395, promoting the
stability of Mdm2 and enhancing the interaction between Mdm2
and p53 (Maya et al., 2001; Lu et al., 2007; Yamaguchi et al., 2007;
Figure 1J).
OTHERS
BRCA1
The breast cancer susceptibility gene BRCA1 plays multiple roles
in the DDR, such as DNA repair and S and G2/M checkpoint con-
trol (Huen et al., 2010). BRCA1 has a RINGﬁnger domain and two
BRCA1 terminal domains (so-called BRCT domains) involved in
associations with other proteins. DNA damage induces the phos-
phorylation of BRCA1 at multiple residues, such as S1524 and
S1423 by ATM and ATR, respectively (Cortez et al., 1999; Tib-
betts et al., 2000), and S988 by Chk2 (Lee et al., 2000). BRCA1
is rapidly localized to damage sites, which contain DNA repair
proteins such as Rad51. The PP1α catalytic subunit interacts with
BRCA1 and dephosphorylates the sites phosphorylated by ATM,
ATR, and Chk2 (Liu et al., 2002; Hsu, 2007; Figure 1K). Muta-
tional research of the PP1-binding motif in BRCA1 has revealed
that the interaction between BRCA1 and PP1α is important for
proper relocation of BRCA1 and Rad51 to DNA damage sites
and consequently is important for the DNA repair function of
BRCA1. In addition, BRCA1 inhibits PP1α activity, although the
precise mechanism underlying this regulatory event remains to be
determined (Liu et al., 2002).
KAP1
Phosphorylation of KAP-1 by ATM has been implicated in chro-
matin relaxation at sites of DSBs (Ziv et al., 2006; Goodarzi et al.,
2008), a process that is necessary to permit the recruitment of
DDR factors to the damaged DNA. Lee et al. (2010) extensively
studied KAP-1 as a PP4 substrate and found that PP4 controls 2IR-
mediated phosphorylation sites on KAP-1, i.e., ATM-dependent
phosphorylation at S824, which is important for transcriptional
repression of heterochromatin, and Chk2-dependent phospho-
rylation at S473, which is involved in the G2/M DNA damage
checkpoint (Lee et al., 2010; Figure 1L). Moreover, a recent study
also revealed that PP1 mediates dephosphorylation of KAP1 at
S473 and sumoylation of KAP-1 to counter the effect of ATM (Li
et al., 2010; Figure 1L).
RPA2
RPA is a trimeric protein complex involved in DNA replication,
DNA repair, and recombination. ATM, ATR, and DNA-PK phos-
phorylate one of the subunits, RPA2, and this phosphorylation
event is important for the DNA repair function of the enzyme
(Wang et al., 2001; Sakasai et al., 2006; Anantha et al., 2007). In
addition to phosphorylation, timely dephosphorylation of RPA2
is required for the recruitment of the homologous recombination
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factor Rad51 and RPA2 itself to damaged sites, which facilitates
DNA repair (Lee et al., 2010). PP4 dephosphorylates the RPA2
subunit at multiple sites, of which S33 seems to be critical for the
function of RPA2 after DNA damage, and PP4R2 mediates the
DNA damage-dependent interaction of RPA2 and PP4C, the PP4
catalytic subunit (Lee et al., 2010; Figure 1M). It has also been
reported that PP2A is involved in the dephosphorylation of RPA2
after hydroxyurea treatment (Feng et al., 2009; Figure 1M).
53BP1
53BP1 is phosphorylated and recruited to DNA damage sites and
plays a role in the DDR, including the DNA damage checkpoint
and DNA repair. PP5 has been shown to regulate the function of
53BP1 after DNA damage through dephosphorylation at S1778
and release of phospho-53BP1 foci following NCS treatment
(Kang et al., 2009; Figure 1N).
CONCLUSION
Spatial and temporal phosphorylation/dephosphorylation events
are critical for the cellular response to DNA damage. Although
much work has focused on the regulation of kinases and phos-
phorylation events, recent reports has revealed the involvement
of protein phosphatases in the DDR and have extensively docu-
mented the physiological roles of dephosphorylation. As discussed
in this review, protein phosphatases have multiple functions in
the activation and inactivation of the DDR through numerous
dephosphorylation events. However, several questions remain to
be investigated. First, it is not clear how the activity of each phos-
phatase is regulated to induce dynamic dephosphorylation events
following DNA damage. In the case of PP1, DNA damage trig-
gers dissociation of PP1 and its inhibitory subunits, resulting in
the activation of PP1 (Tang et al., 2008). So far, nearly 700 PP1
interacting proteins (PIPs) have been isolated; the identiﬁcation
of speciﬁc PIPs for each isoform may also help us to understand
the individual roles of these proteins. It is possible that each asso-
ciated factor is modiﬁed by phosphorylation, thereby affecting
its interaction with PP1 and altering PP1 activity. It is essential
to analyze the precise mechanisms of activation for each phos-
phatase/substrate combination. Second, in some cases, distinct
phosphatases are reported to control the same substrate sites. The
purpose of such multi-phosphatase regulation is unclear. More-
over, it is not known whether speciﬁc phosphatases are directly
involved in the dephosphorylation of target proteins because
depletion of certain phosphatase causesmultiple effects, including
indirect effects on the phosphorylation of target proteins.
It can be speculated that multiple phosphatases regulate dif-
ferent populations of targets at speciﬁc regions, such as DNA
damage sites and genes whose expression is repressed or activated.
Future work is required to determine the precise spatial patterns
of phosphorylation events at speciﬁc time points.
Importantly, protein phosphatases may be targets for cancer
therapy. Mice lacking Wip1 are resistant to spontaneous and
oncogene-induced tumors (Choi et al., 2002; Hirasawa et al., 2003;
Saito-Ohara et al., 2003; Bulavin et al., 2004). In addition, double
knockout of ATM and Wip1 in mice rescues several phenotypes
observed in ATM-null mice, such as thymic lymphomas (Dar-
lington et al., 2012), possibly due to enhanced DDRs caused by
Wip1 depletion. Although inhibition of PP1 or PP2A has some
effects on reduced tumor resistance to radiation or chemother-
apy (Hamilton et al., 2009; Lu et al., 2009), it is difﬁcult to apply
protein phosphatase inhibitors for cancer therapy because they
also affect many other cellular events in vivo. In contrast, tar-
geting speciﬁc disruption of the interaction between substrates
and protein phosphatases may be useful for cancer therapy. In
fact, loss of Repo-Man has been reported to reduce anchorage-
independent growth of tumor cells in soft agar (Peng et al., 2010).
Thus, it is important for cancer therapy to understand the mecha-
nisms underlying the functions and regulation of phosphatases in
the DDR.
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